Quantum Cyber N.V. Gains Losses Recognised When Control In Subsidiary Is Lost
Quantum Cyber N.V. (QUCY) reported Gains Losses Recognised When Control In Subsidiary Is Lost of $28.33 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost · last filed 2025-03-31
| Period end | Gains Losses Recognised When Control In Subsidiary Is Lost 12 month |
|---|---|
| 2024-12-31 | $28.33K 20-F · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |